Concepedia

Xinshuai Wang

XW

Statistics

Publications

8

Citations

329

H-Index

8

Active since

2017

Affiliations

Henan University of Science and Technology(Current)

UC Davis Comprehensive Cancer Center

University of California, Davis

First Affiliated Hospital of Henan University of Science and Technology

Henan Cancer Hospital

Xinshuai Wang is an author at Henan University of Science and Technology specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2017–2023

8

Publications

8

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial

Fei Ma, Min Yan, Wěi Li et al. · BMJ · 2023 · 84 citations · Full text

, , +17

Different frequencies of Porphyromonas gingivalis infection in cancers of the upper digestive tract

Xiang Yuan, Yiwen Liu, Jinyu Kong et al. · Cancer Letters · 2017 · 77 citations

, , +16

Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis

Limin Wei, Xinyang Li, Ziming Wang et al. · Gland Surgery · 2021 · 66 citations · Full text

, , +17

Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy

Xiangdong Xue, Yee Huang, Xinshuai Wang et al. · Biomaterials · 2018 · 37 citations

, , +16

Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer

Jing Chen, Shuzhen Deng, Yifan Zhang et al. · Annals of Translational Medicine · 2021 · 19 citations · Full text

, , +17

1–5 of 8